Medication prepared for people affected by Covid-19, Remdesivir is a selective antiviral prophylactic against virus that is already in experimental use, conceptual image

Matt Hancock has confirmed that the government will be trialing the antiviral drug, remdesivir on NHS patients.

Speaking at the Downing Street Press Conference  he said:

“There’s already been some promising early results on coronavirus patients, with early data suggesting it can shorten recovery time by around four days. As you can understand, we’ll be prioritising the use of this treatment where it will provide the greatest benefit.”

“This is probably the biggest step forward in the treatment of coronavirus since the crisis began.”
“These are very early steps, but we’re determined to support the science and back the projects that show promise.”


Please enter your comment!
Please enter your name here